Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mesa Biotech

Mesa Biotech
2009 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series C LATEST DEAL TYPE
$3M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of molecular diagnostic test designed to treat infectious diseases. The company's test uses revolutionary technology which offers the simplicity, convenience and procedural familiarity of traditional point of care rapid immunoassays while offering superior sensitivity, specificity of laboratory-based molecular testing, enabling healthcare professionals to access actionable, laboratory-quality results at the point-of-care with greater sensitivity and specificity than current infectious disease rapid immunoassay tests.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 6190 Cornerstone Court East
  • Suite 220
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mesa Biotech’s full profile, request a free trial.

Mesa Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 28-Oct-2019 $3M 0000 0000 Completed Generating Revenue
5. Later Stage VC (Series B) 09-Jul-2018 0000 0000 0000 Completed Generating Revenue
4. Later Stage VC (Series A) 13-Feb-2018 0000 0000 0000 Completed Generating Revenue
3. Grant 01-Jun-2015 00.000 Completed Generating Revenue
2. Grant Completed Generating Revenue
1. Grant 11-Aug-2009 $100K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Mesa Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A 395,631 $0.000010 6% $7.59 $7.59 1x $7.59 3.98%
To view this company’s complete Cap Table, request access »

Mesa Biotech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
New Mexico Venture Acceleration Fund Accelerator/Incubator 000 0000 000000 0
American Recovery and Reinvestment Act Government 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
California Citrus Research Board Other 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Mesa Biotech Executive Team (6)

Name Title Board
Seat
Contact
Info
Hong Cai Ph.D Co-Founder, Board Member, President & Chief Executive Officer
Thomas Willardson Chief Financial Officer
John Monroe Chief Operating Officer
Robert Cary Ph.D Co-Founder, Board Member & Chief Scientific Officer

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Mesa Biotech Board Members (5)

Name Representing Role Since Contact
Info
Eric Sagerman Self Board Member 000 0000
Hong Cai Ph.D Mesa Biotech Co-Founder, Board Member, President & Chief Executive Officer 000 0000
Robert Cary Ph.D Mesa Biotech Co-Founder, Board Member & Chief Scientific Officer 000 0000
Wen Chen Self Board Member 000 0000
William Brody Ph.D Self Chairman 000 0000